Acute pancreatitis and diabetes risk study
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at how acute pancreatitis affects blood sugar and the risk of developing diabetes. You'll wear a continuous glucose monitor (CGM) sensor and have metabolic tests to track changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had acute pancreatitis within the last 90 days.
- You do not have chronic pancreatitis (long-term scarring or calcium deposits in the pancreas).
- You have not had any pancreatic surgery, tumor, or cyst.
- You are not pregnant, incarcerated, or on certain medications that are not allowed (the study team will check this).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people develop diabetes after acute pancreatitis and how that process works in the body. It may help doctors better predict risk and tailor care for people recovering from pancreatitis.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This trial studies how “inflammation” in the pancreas changes over time—going from a first or repeated attack to long-term (chronic) pancreatitis. It may help doctors understand what drives progression and identify people at higher risk for chronic disease.
This study looks at how gut bacteria change during acute pancreatitis and whether analyzing them can help predict how severe the condition will become. It may lead to better treatments and faster recovery.
This study looks at how the pancreas affects blood sugar and diabetes. It may help find better ways to prevent or treat type 2 diabetes.
This study watches blood sugar levels in people hospitalized with acute pancreatitis. It checks if low insulin and gut bacteria affect sugar levels, and uses a small sensor on the skin (continuous glucose monitor) to track sugar without frequent finger pricks.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.